Video

OAB treatment adherence: Navigator impact and additional challenges

“I think the take-home point here is that patient-centered care in the form of navigators to help support patients and provide those frequent check ins really appears to help improve adherence to therapy and progression to advanced therapies,” says Ekene Enemchukwu, MD, MPH.

In this video, Ekene Enemchukwu, MD, MPH, discusses the findings and takeaways of the study, “Identifying navigator impact on utilization of onabotulinumtoxinA as a third-line treatment in overactive bladder: A retrospective database study in the United States.” This study was presented at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting. Enemchukwu is a pelvic reconstruction surgeon at Stanford Health Care, and an assistant professor of urology and obstetrics and gynecology at the Stanford University School of Medicine in California.

Related Videos
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Woman at doctor | Image Credit: © rocketclips - stock.adobe.com
Closeup of patient with prescription | Image Credit: © gpointstudio - stock.adobe.com
Colin Goudelocke, MD, answers a question during a Zoom video interview
Shot of a doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Colin Goudelocke, MD, answers a question during a Zoom video interview
Vanita Gaglani, RPT, answers a question during a video interview
© 2025 MJH Life Sciences

All rights reserved.